Healthcare IT News January 15, 2018
A growth projection of 25.6 percent by 2022 is expected, says new Kalorama report, and so are changes in the doctor-patient relationship.
As people learn more about the crucial role of genetics in health and the cost to sequence genes continues to decrease, the worldwide market for direct-to-consumer genetic tests could triple over the next five years, according to a new report from Kalorama Information.
The DTC genetic testing market was around $99 million this past years, according to the research firm, and could grow to more than $310 million in 2022.
Consumers are looking for more control over their own health and healthcare, and with the advent of affordable genetic testing there are new avenues for personalized treatment and...
Today's Sponsors
Today's Sponsor